Wieboldt, Ronja
Sandholzer, Michael
Carlini, Emanuele
Lin, Chia-wei http://orcid.org/0000-0003-4777-2916
Börsch, Anastasiya
Zingg, Andreas
Lardinois, Didier
Herzig, Petra
Don, Leyla
Zippelius, Alfred
Läubli, Heinz http://orcid.org/0000-0002-8910-5620
Mantuano, Natalia Rodrigues
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030-184720)
Krebsliga Schweiz
Krebsliga Beider Basel
Article History
Received: 14 August 2023
Accepted: 30 January 2024
First Online: 6 March 2024
Competing interests
: HL received travel grants and consultant fees from Bristol-Myers Squibb (BMS), Alector, InterVenn, GlycoEra, and Merck Sharp & Dohme (MSD). HL received research support from BMS, Novartis, GlycoEra, Ono Pharmaceuticals and Palleon Pharmaceuticals. HL and NMR are cofounders of Glycocalyx Therapeutics AG. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.